Safi Biosolutions

About:

Safi Biosolutions is biotechnology based company.

Website: https://safi.bio

Top Investors: J2 Ventures

Description:

As the cell therapy commercialization partner of a 5-year Department of Defense program to manufacture on-demand blood products, Safi Biosolutions and its collaborators are working to ‘crack the code’ of Cell Therapy 2.0 challenges of manufacturing at appropriate scale, high consistency of product, and economically viable cost of goods by integrating world-leading expertise in cord blood stem cell expansion, bioprocessing optimization, manufacturing scale-up and cryostorage.

Total Funding Amount:

$5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Arlington, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-09-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai